Navellier & Associates Inc Amphastar Pharmaceuticals, Inc. Transaction History

Navellier & Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$42.85 - $63.45 $1.15 Million - $1.7 Million	26,864 Added 347.66%	34,591 $1.52 Million
Q4 2023 Feb 08, 2024	BUY	$44.49 - $62.93 $343,774 - $486,260	7,727 New	7,727 $477,000
Q4 2022 Feb 02, 2023	SELL	$27.93 - $31.27 $263,547 - $295,063	-9,436 Reduced 41.77%	13,155 $368,000
Q3 2022 Nov 09, 2022	SELL	$27.56 - $37.75 $4,905 - $6,719	-178 Reduced 0.78%	22,591 $635,000
Q2 2022 Aug 12, 2022	BUY	$29.79 - $42.29 $923 - $1,310	31 Added 0.14%	22,769 $792,000
Q1 2022 Apr 29, 2022	BUY	$22.96 - $36.45 $522,064 - $828,800	22,738 New	22,738 $816,000

279

34.2M

25.5K

24.8K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.35B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Navellier & Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Navellier & Associates Inc with notifications on news.